Contact Us   |   Sign In   |   Register

2018 Wyoming Legislature Completed

The Budget Session of the 64th Wyoming Legislature finished on March 15th.  This shortened session, designed to concentrate primarily on budget issues and bills, did not have many enacted bills affecting pharmacy practice in Wyoming.  The bills that affected pharmacy are stated below; please look to the legislature website and future Board of Pharmacy communications to learn more about the specific bills.

SF 75 -  Biosimilar Bills -  This bill will directly affect pharmacy practice, especially in years to come as more and more biosimilar products are produced.  This bill allows biosimilar products to be substituted by pharmacists if the product is considered "interchangeable" by the FDA.  There is a specific process a pharmacist must do in this instance, notably giving the practitioner notice of the product used within 5 business days.  If a product is considered biosimilar, but not interchangeable, then the prescriber must be notified and agreeable to any change in product prior to the prescription being dispensed.  Please be aware of the current rules prior to initiating any substitution or interchange.

SF 78 -  Opioid Drug Task Force -  This bill forms a multi-disciplinary task force to address the current opioid drug epidemic in our state.  The committee will be made up of pharmacists, other health professionals, and legislators.  There purpose will be to learn about the issue, propose solutions, and use legislative authority to influence change.

SF 83 -  Controlled Substance Prescription Tracking updates -  This bill requires more health care practitioners in varying health care fields to register with the State Board of Pharmacy and to utilize the PDMP system.  This bill will not directly affect pharmacists but it should allow for more thorough profiles when receiving patient profiles from the WORx program

HB 99 -  FDA Approved Drugs -  This bill reinforces that all FDA drugs may be prescribed and possessed by the intended recipient.  The purpose of this bill is to make sure that only prescriptions containing marihuana and THCs in FDA approved drugs are legal.

Pharmacist's can now Dispense Naloxone -- Make sure you're following the rules.

As of July 1st, 2017, licensed Wyoming pharmacists may begin prescribing naloxone pursuant to the Emergency Administration of Opiate Antagonist Act.  Here is a brief summary of the important aspects of the rules but it is highly recommended that you read the rules in their entirety on the Wyoming Board of Pharmacy website prior to prescribing.

--  Pharmacists may prescribe any dosage form of naloxone without a prescriber-patient relationship to the following patient groups:
         --  Patients who are at risk for an opiate related overdose
         --  A person in a position to assist someone who is at risk of an opiate related drug overdose (i.e. family member)
         --  A person who, in the course of their job, may encounter a person experiencing an opiate related drug overdose
--  Pharmacists must provide appropriate counseling when they prescribe naloxone, including:
         --  How to prevent, recognize, and respond to an overdose
         --  How to administer naloxone in the event of an overdose
         --  Naloxone is an opioid antagonist that reverses effects in 2 - 3 minutes and may only last 30 minutes
         --  Naloxone is not abusable and is not a controlled substance.
         --  Opioid-dependent patients will be sent into withdrawal
         --  If naloxone is administered, additional medical help must be called ASAP
--  Pharmacists must complete a minimum of one hour continuing education specific to naloxone prior to prescribing
--  A prescription hardcopy is required when a pharmacist prescribes naloxone, with the pharmacist as prescriber.
--  Prescriptions for naloxone should be reported to the PDMP in the process used for controlled substances.
--  Pharmacists are not required to report naloxone prescriptions to the patient's primary care provider.

Be on the lookout for naloxone education courses in your area!


Pharmacy Related Bills Pass Legislature

WPhA was actively involved in 3 legislative bills this session which were all passed.

SF0042 - Naloxone Bill - this bill allows pharmacists to prescribe for the drug naloxone as well as increases the opportunity for first responders to gain access to naloxone.  The Board of Pharmacy and the Board of Medicine will now develop rules to accompany the law changes.

SF0062 - Telepharmacy Bill - this bill removes some barriers and obstacles faced by pharmacies potentially opening telepharmacies in our state.  Hopefully this bill will encourage more telepharmacies in order to improve patient access and safety.

SF0121 - Pharmacy Act Changes - This bill was basically a "clean-up" bill to update inappropriate wording and to better describe current pharmacy practices.

All of the bills can be read in their entirety at under "2017 Bill Tracking" then "Bills" then find the number of the bill, move to the right and click on "SEA00??"

 Executive Director Bio and Vision

A new Executive Director for WPhA has been hired.  Craig Frederick, PharmD, has been chosen to replace Kara Beech who served the Association for nearly 10 years.  Craig is the owner and pharmacist-in-charge of Register Cliff Pharmacy in Guernsey, Wyoming.  Dr. Frederick has practiced in Wyoming since graduating from the University of Wyoming School of Pharmacy in 2000.  He has been a member of WPhA since 2006 and served as President of WPhA in 2009-2010.

Under the direction of the board, Dr. Frederick will be focusing on these priorities:

1)   Exploring ways to bring our message to the membership and  implement strategies to improve the sharing and exchanging of information with the members.

2)   Utilize technology to better address the educational needs of the membership.

3)   Implement a legislative committee and actively pursue or promote legislative issues and changes.

4)   Strengthen the Association's relationship with the UW School of Pharmacy, especially in promoting and supporting student activities and educational opportunities. 

Feel free to contact Craig by email, or by phone 307-331-0371.



Community Search
Sign In


Winter CE Event

Newest Members